Outcomes of SARS-CoV-2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort

Meret K Huber^#¹, Claudia Raichle^#², Paul Lingor^{3

4}, Matthis Synofzik^{5

6}, Stefan Borgmann⁷, Johanna Erber⁸, Lukas Tometten⁹, Wolfgang Rimili¹⁰, Sebastian Dolff¹¹, Kai Wille¹², Samuel Knauss¹³, Christiane Piepel¹⁴, Julia Lanznaster¹⁵, Siegbert Rieg¹⁶, Fabian Prasser¹⁷, Lisa Pilgram¹⁸, Annika Spottke^{19

20}, Thomas Klockgether^{19

20}, Christine Klein²¹, Franziska Hopfner^#¹, Günter U Höglinger^#^{1

4}; LEOSS Study Group

Affiliations

¹ Department of Neurology, Hannover Medical School, Hannover, Germany.
² Tropical Clinic Paul-Lechler Hospital, Tübingen, Germany.
³ Department of Neurology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
⁴ German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
⁵ Department of Neurodegenerative Diseases, Centre for Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
⁶ German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
⁷ Department of Infectious Diseases and Infection Control, Hospital of Ingolstadt, Ingolstadt, Germany.
⁸ School of Medicine, University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany.
⁹ Department I for Internal Medicine, University Hospital of Cologne, University of Cologne, Cologne, Germany.
¹⁰ Department of Internal Medicine, Stiftung Kreuznacher Diakonie, Rhaunen, Germany.
¹¹ Department of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
¹² University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, UKRUB, University of Bochum, Minden, Germany.
¹³ Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
¹⁴ Department of Hemato-Oncology and Infectious Diseases, Klinikum Bremen-Mitte, Bremen, Germany.
¹⁵ Department of Internal Medicine, Hospital Passau, Passau, Germany.
¹⁶ Medical Center-University of Freiburg, Division of Infectious Diseases, Department of Medicine II, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
¹⁷ Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
¹⁸ Department of Internal Medicine, Hematology and Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.
¹⁹ German Center for Neurodegenerative Diseases, Bonn, Germany.
²⁰ Department of Neurology, University of Bonn, Bonn, Germany.
²¹ Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.

^# Contributed equally.

PMID: 33638915
PMCID: PMC8014567
DOI: 10.1002/mds.28554

Outcomes of SARS-CoV-2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort

Meret K Huber et al. Mov Disord. 2021 Apr.

. 2021 Apr;36(4):791-793.

doi: 10.1002/mds.28554. Epub 2021 Feb 27.

Authors

Affiliations

¹ Department of Neurology, Hannover Medical School, Hannover, Germany.
² Tropical Clinic Paul-Lechler Hospital, Tübingen, Germany.
³ Department of Neurology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
⁴ German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
⁵ Department of Neurodegenerative Diseases, Centre for Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
⁶ German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
⁷ Department of Infectious Diseases and Infection Control, Hospital of Ingolstadt, Ingolstadt, Germany.
⁸ School of Medicine, University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany.
⁹ Department I for Internal Medicine, University Hospital of Cologne, University of Cologne, Cologne, Germany.
¹⁰ Department of Internal Medicine, Stiftung Kreuznacher Diakonie, Rhaunen, Germany.
¹¹ Department of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
¹² University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, UKRUB, University of Bochum, Minden, Germany.
¹³ Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
¹⁴ Department of Hemato-Oncology and Infectious Diseases, Klinikum Bremen-Mitte, Bremen, Germany.
¹⁵ Department of Internal Medicine, Hospital Passau, Passau, Germany.
¹⁶ Medical Center-University of Freiburg, Division of Infectious Diseases, Department of Medicine II, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
¹⁷ Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
¹⁸ Department of Internal Medicine, Hematology and Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.
¹⁹ German Center for Neurodegenerative Diseases, Bonn, Germany.
²⁰ Department of Neurology, University of Bonn, Bonn, Germany.
²¹ Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.

^# Contributed equally.

PMID: 33638915
PMCID: PMC8014567
DOI: 10.1002/mds.28554

No abstract available

PubMed Disclaimer

References

1. Jakob CEM, Borgmann S, Duygu F, Behrends U, Hower M, Merle U, et al. First results of the “lean European open survey on SARS‐CoV‐2‐infected patients (LEOSS)”. Infection 2021;49:63–73. 10.1007/s15010-020-01499-0. - DOI - PMC - PubMed
1. Enders D, Balzer‐Geldsetzer M, Riedel O, Dodel R, Wittchen HU, Sensken SC, et al. Prevalence, duration and severity of Parkinson's disease in Germany: a combined meta‐analysis from literature data and outpatient samples. Eur Neurol 2017;78(3–4):128–136. 10.1159/000477165 - DOI - PubMed
1. Trenkwalder C, Schwarz J, Gebhard J, Ruland D, Trenkwalder P, Hense HW, et al. Starnberg trial on epidemiology of parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a door‐to‐door survey of inhabitants older than 65 years. Arch Neurol 1995;52(10):1017–1022. 10.1001/archneur.1995.00540340109020 - DOI - PubMed
1. Bickel H. Demenzsyndrom und Alzheimer Krankheit: Eine Schätzung des Krankenbestandes und der jährlichen Neuerkrankungen in Deutschland. Das Gesundheitswesen 2000;62(04):211–218. 10.1055/s-2000-10858 - DOI - PubMed
1. Jessen, F, Handbuch Alzheimer‐Krankheit: Grundlagen – Diagnostik – Therapie – Versorgung – Prävention, De Gruyter; 1. Edition, ISBN‐10: 3110403455.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Outcomes of SARS-CoV-2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort

Affiliations

Outcomes of SARS-CoV-2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort

Authors

Affiliations

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous